Fig. 5.
![Fig. 5. Increase of trf-rec mRNA concentration upon Epo-treatment of K562 cells. K562 cells were treated for 24 hours with 50 μmol/L Fe(NO3 )3 (I), 100 μmol/L desferrioxamine (D), or the indicated concentrations of human recombinant Epo (Epo) or remained untreated (control [C]). The total RNA was then extracted and 10 μg was subjected to Northern blotting with a human trf-rec cDNA or a rat GAPDH probe. The results of one of three similar experiments are shown.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/89/2/10.1182_blood.v89.2.680/4/bl_0026f5.jpeg?Expires=1735843499&Signature=AvBXRpUt9UcpgJy0U0K30DjzRZsRsS-FHhv2ohzBPoRW-TPVDap7e63YVN-qnQ8EizPCKtzrqqe-WW8vzhsEEmFW56katZGilEhc2dA9KIh5dAYHD11MsLcLvYpD~0sAwD8kWboP0MI~lSGGe9xzxFr~m-XTHwvrvsRbaex0abHyxpWOmyhWkBw4-EDRQ0ygp3lgv9rd0sxrDYKCy78RsBO7lmWJKRbJKUdlR0uimRWyXmbNw~VuDol~MNA7Lvz4YwX-6Nd5G30sgPbTzf1DjPqYBkxWO4c~StAeaLrdT~CmcISF4WwnbSaglA~Vree6JxntlE9H0EB06LAXYo9V6A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Increase of trf-rec mRNA concentration upon Epo-treatment of K562 cells. K562 cells were treated for 24 hours with 50 μmol/L Fe(NO3 )3 (I), 100 μmol/L desferrioxamine (D), or the indicated concentrations of human recombinant Epo (Epo) or remained untreated (control [C]). The total RNA was then extracted and 10 μg was subjected to Northern blotting with a human trf-rec cDNA or a rat GAPDH probe. The results of one of three similar experiments are shown.
